Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Maine for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Maine only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Maine (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Cvs State Capital, L.L.C. (NPI 1588811699)

Field	Value
Entity Type	Organization
Organization	Cvs State Capital, L.L.C.
Address	11 Steeple Way
City	Wells
State	ME
ZIP	04090
Taxonomy	Pharmacy
NPI Enumerated	August 20, 2008

Payer Source	Total Paid
Medicare	$254.6K
Medicaid	$0

Key Findings

CVS STATE CAPITAL, L.L.C. operates as a pharmacy-focused provider whose Medicare billing is dominated by immunizations and COVID-related services. The top Medicare codes are vaccination and testing codes (for example, 91320, 90694, 90662 and administration codes such as 90480 and G0008), which together reflect a retail pharmacy model that delivers routine influenza and pneumococcal immunizations alongside COVID vaccination activity. Claims counts and code mix are consistent with point-of-care immunization and over-the-counter test distribution rather than episodic medical procedures.

Revenue concentration is high within a small set of preventive-care codes: the precomputed top 3 Medicare codes account for 64.7% of this provider’s total Medicare revenue, and those three codes are 91320 ($87.9K, 34.7%), K1034 ($38.8K, 15.3%) and 90694 ($37.5K, 14.8%). This concentration signals that a majority of Medicare dollars received by this entity come from a narrow set of vaccine and COVID-test related services, making overall Medicare revenue sensitive to demand and reimbursement changes for those codes.

This provider is effectively single-payer in the dataset: total Medicare revenue is $254.6K while there is no Medicaid billing on file. The absence of Medicaid activity indicates that analyses of payer mix, utilization trends, and competitive positioning should be framed around Medicare and commercial/retail channels rather than state Medicaid dynamics, since Medicaid does not contribute measurable revenue here.

Competitive standing on core codes is notable in raw rank terms but is characterized by the source data as routine for similar providers. For example, 91320 ranks #211 of 27083 providers (99th percentile), 90694 ranks #763 of 51679 providers (99th percentile), and K1034 ranks #957 of 30143 providers (97th percentile); however, the dataset labels these placements as "typical, unremarkable volume for this code," indicating that while the provider is in the upper national percentiles for these vaccinations and tests, such volume is common among pharmacy peers offering the same services. Analysts should interpret these high ranks as strong participation in widespread retail immunization/testing activity rather than unique market dominance.

The provider’s utilization and payment mix shows a combination of higher-paid vaccine claims and very-high-volume, low-paid test claims that together drive revenue. Notable examples are 91320 with 687 claims at $128 avg paid/claim generating $87.9K, K1034 with 3.5K claims at $11 avg paid/claim generating $38.8K, and 90694 with 500 claims at $75 avg paid/claim generating $37.5K; this pattern indicates revenue is produced both by per-dose reimbursement for vaccines and by scale of test distribution. Monitoring both claim counts and average paid per claim is important because shifts in either utilization or unit payment will materially affect total Medicare revenue.

Several influenza and vaccine administration codes appear across the top lines, reinforcing seasonal vaccination as a key service line. G0008 (825 claims, $30 avg paid/claim, $24.8K) and 90480 (689 claims, $40 avg paid/claim, $27.6K) are prominent and are ranked in high national percentiles (G0008 listed at the 100th percentile), but again are described in the data as "typical, unremarkable volume for this code," which suggests the provider’s influenza vaccination activity mirrors common retail pharmacy behavior rather than indicating a specialty immunization clinic.

The provider has long-term presence in the NPI registry, which supports stable operational tenure: the NPI was enumerated 2008-08-20 (~18 years ago). This duration in the registry is consistent with an established retail pharmacy operation; combined with the concentrated vaccine/test revenue profile, it suggests sustained delivery of community immunization and testing services over time.

Operationally, the exceptionally high claim count for K1034 (3.5K claims) relative to other codes highlights a pronounced distribution of self-administered COVID tests. That volume, paired with substantial claims for vaccine product codes, points to a dual retail role—both as a vaccination site and as a point-of-sale/distribution channel for consumer COVID testing—making the site sensitive to public health demand cycles and retail test availability.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

12 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
91320	This code represents a SARS–CoV–2 vaccine product (tris–sucrose formulation) administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 30 mcg/0.3 mL.	690	$130	$87.9K
K1034	Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count	3,520	$10	$38.8K
90694	This code represents a vaccine product administered into the muscle to protect against four strains of influenza (flu). It is an inactivated, adjuvanted, preservative–free vaccine given as a 0.5 mL…	500	$80	$37.5K
90480	The provider administers the first or only component of a SARS–CoV–2 (COVID–19) vaccine by intramuscular injection to reduce the patient's risk of contracting COVID–19.	690	$40	$27.6K
G0008	Administration of influenza virus vaccine	830	$30	$24.8K
90662	This code represents a flu vaccine product that is a split virus type, contains no preservatives, and has enhanced effectiveness due to a higher antigen content. It is administered as an injection…	300	$70	$21.5K
90677	This code represents a vaccine product administered intramuscularly to protect against pneumococcal disease, a bacterial infection. This is a 20–valent vaccine, protecting against 20 strains of the…	30	$280	$8.7K
0124A	N/A	130	$40	$5.3K
0121A	N/A	10	$40	$560
G0009	Administration of pneumococcal vaccine	30	$20	$470

Showing 1–10 of 12

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 12 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Maine Distribution

Cvs State Capital, L.L.C. — 7 of 12 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Maine

Full comparison — all codes billed, vs. state median

12 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
91320	3	80	40	$130	$15K
K1034	4	100	510	$10	$9.7K
90677	15	90	20	$270	$6.2K
90694	3	140	50	$80	$5.7K
90662	7	230	30	$70	$4.6K
90480	3	200	60	$30	$3.9K
G0008	3	340	50	$30	$2.5K
0124A	1	80	20	$40	$1.1K
G0009	13	100	20	$30	$570
0121A	2	10	10	$40	$550

Showing 1–10 of 12

Nearby Providers

Other providers in the same ZIP code as Cvs State Capital, L.L.C., ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Ycpd, PLLC	ME	Pediatric Dentistry	$0	$794.9K
Wells Emergency Medical Service Inc	ME	Land Ambulance	$287.2K	$188.5K
Michael Hatton	ME	Pediatric Dentistry	$0	$462.6K
Shields Imaging At York Hospital LLC	ME	Mobile Radiology Clinic/Center	$417K	$0
Jeffrey Cote	ME	Family Medicine Physician	$70K	$0
Jill Dimartinis	ME	Family Medicine Physician	$67.2K	$0
Jane Pelletier	ME	Physician Assistant	$14.8K	$0
Jane Adams	ME	Obstetrics & Gynecology Nurse Practitioner	$1.9K	$0

Cvs State Capital, L.L.C. — Billing Profile & Reimbursement Data

Sign up for Cvs State Capital, L.L.C. — Billing Profile & Reimbursement Data policy alerts

Cvs State Capital, L.L.C. — Billing Profile & Reimbursement Data

Sign up for Cvs State Capital, L.L.C. — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Nearby Providers

Frequently Asked Questions

References